Migdal Insurance & Financial Holdings Ltd. Passage Bio, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$5.99 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$12.44 - $19.45 $351,641 - $549,793	-28,267 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$16.24 - $29.83 $284,882 - $523,277	17,542 Added 163.56%	28,267 $494,000
Q4 2020 Feb 08, 2021	BUY	$14.28 - $29.73 $153,153 - $318,854	10,725 New	10,725 $274,000

Others Institutions Holding PASG

# of Institutions

Shares Held

32.7M

Call Options Held

8.3K

Put Options Held

400

Orbimed Advisors LLC San Diego, CA

10.1M
Shares

$7.09 Million
0.19% of portfolio
Vestal Point Capital, LP New York, NY

6.05M
Shares

$4.24 Million
0.36% of portfolio
Versant Venture Management, LLC San Francisco, CA

4.03M
Shares

$2.82 Million
7.06% of portfolio
New Leaf Venture Partners, L.L.C. New York, NY

2.5M
Shares

$1.75 Million
2.4% of portfolio
Vanguard Group Inc Valley Forge, PA

2.07M
Shares

$1.45 Million
0.0% of portfolio

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $38.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account